Overview
The fund is managed with an indexed method and is distinguished by broad diversification, low tracking errors, and low-cost management.
The investment objective is to replicate the reference index as closely as possible and to minimize performance deviations from the benchmark.
The MSCI Switzerland Index is designed to measure the performance of the large and mid cap segments of the Swiss market.
The index covers approximately 85% of the free float-adjusted market capitalization in the Swiss equity universe.
The fund is passively managed.
Benefits
Easy access to a broadly diversified portfolio of Swiss Equities.
Provides access to the performance of the index with a single transaction.
The fund is transparent and cost-effective and is liquid under normal market conditions.
You do not pay any federal stamp duty.
Risks
Features
| Product category |
Equity Switzerland |
| Product domicile |
Switzerland
|
| Portfolio management |
UBS SA国际传谋 Switzerland AG, Zurich
|
| Fund management |
UBS Fund Management (Switzerland) AG
|
| Custodian bank |
UBS Switzerland AG, Zurich
|
| Day of inception |
September 9, 2016
|
| Currency of account |
CHF
|
| Close of financial year |
February 28
|
| SFDR Classification |
n.a.
|
| Issue / redemption |
daily
|
| Distribution |
Reinvestment
|
| Maturity |
Open end
|
| Ongoing costs p.a. |
0.25% p.a.
|
| Flat fee |
0.19% p.a.
|
| Management fee |
0.19% p.a.
|
| Total expense ratio (TER) |
0.22% p.a.
|
| Minimum investment |
n.a.
|
| Reference Index / Benchmark |
MSCI Switzerland (TR) in CHF
|
| Cut-Off Time |
14:00h(CET)
|
| Securities no. |
33620673
|
| ISIN |
CH0336206732
|
| Bloomberg Ticker |
CSSWBFA SW
|
| Reuters Id |
33620673X.CHE
|
Performance and Prices
Percentage growth
as of April 23, 2026| CHF(%) | EUR(%) | USD(%) | |
| YTD | 2.32 | 3.74 | 3.44 |
| 1M | |||
| 3M | |||
| 6M | |||
| 1Y | |||
| 2Y | 17.54 | 18.54 | 34.45 |
| 3Y | |||
| 5Y | 30.02 | 56.52 | 52.13 |
| ø p.a.5Y | 5.39 | 9.37 | 8.75 |
Current data
| Net asset value | 23.04.2026 | CHF 1,901.15 |
| High - last 12 months | 27.02.2026 | CHF 1,959.26 |
| Low - last 12 months | 24.04.2025 | CHF 1,657.35 |
| Assets of the unit class in mn | 23.04.2026 | CHF 4.43 |
| Total product assets in mn | 23.04.2026 | CHF 753.56 |
|
Date
|
2 years
|
5 years
|
|
| Total risk reference index / benchmark | 31.03.2026 | 12.09% | 12.45% |
| Sharpe Ratio | 31.03.2026 | 0.56 | 0.37 |
| Risk Free Rate | 31.03.2026 | 0.46% | 0.40% |
Structures
By the 10 largest positions (in %, as of March 31, 2026)
|
|
|
| Roche Holding AG | 15.36 |
| Novartis AG | 15.24 |
| Nestle SA | 13.40 |
| ABB Ltd | 6.58 |
| UBS Group AG | 6.47 |
| Zurich Insurance Group AG | 5.45 |
| Cie Financiere Richemont SA | 4.94 |
| Swiss Re AG | 2.62 |
| Lonza Group AG | 2.35 |
| Holcim AG | 2.20 |
Fees
Distributions
Sales Authorisations
Literature
|
Document type
|
Document Language
|
|||
| Prospectus |
|
|
||
| Key Information Document |
|
|
|
|
| Past performance |
|
|
|
|
| Previous performance scenario |
|
|
|
|
|
Document type
|
Document Language
|
|
| Annual report |
|
|
| Semi-annual report |
|
|
|
Document type
|
Document Language
|
|||
| Tax list |
|
|
|
|